Medical Research
Explainer
WHO Launches Landmark Global Trial to Find First Effective Treatments for Bundibugyo Virus
5 sources · 64d ago
Explainer
Landmark Study: Circular RNA Blood Test Outperforms Gold Standard in Predicting Alzheimer's Progression
3 sources · 64d ago
Research Brief
FDA Approves Belzutifan and Pembrolizumab Combination as New Standard for High-Risk Kidney Cancer
4 sources · 65d ago
More in Medical Research
Research BriefOncology Breakthrough
Landmark Trial Adds Immunotherapy to Chemo, Halving Recurrence Risk in Stage III dMMR Colon Cancer
Clinical Oncologists 40%Patient Advocacy Groups 30%Regulatory & Industry Analysts 30%
5 sources · 66d ago
ExplainerHER2 Therapies
FDA Approves T-DXd for Early-Stage HER2+ Breast Cancer, Signaling New Standard of Care
Clinical Researchers 47%Regulatory Monitors 35%Industry Analysts 18%
5 sources · 66d ago
Research BriefPrecision Immunology
First-in-Class Extracellular Protein Degrader Enters Phase 3 to Target Root Cause of Graves' Disease
Clinical Trial Investigators 41%Targeted Protein Degradation Pioneers 29%Biotech Industry Analysts 29%
6 sources · 67d ago
Research BriefMantle Cell Lymphoma
Landmark Phase 3 Trial Establishes Chemotherapy-Free Regimen as New Standard for Frontline Mantle Cell Lymphoma
Clinical Hematologists 41%Patient Advocates 29%Regulatory Analysts 29%
5 sources · 67d ago
ExplainerBreast Cancer
Landmark Study Finds Intraoperative PET-CT Significantly Reduces Re-Operation Rates in Breast-Conserving Surgery
Surgical Oncologists 40%Radiology & Imaging Experts 35%Patient Advocates & Trialists 25%
5 sources · 67d ago
Research BriefPrecision Medicine
NIH's All of Us Program Unveils World's Largest Integrated Genomic and Clinical Dataset for Precision Medicine
Precision Medicine Researchers 40%Health Equity Advocates 35%Medical Informaticians 25%
4 sources · 68d ago
ExplainermRNA Vaccines
Personalized mRNA Cancer Vaccines Advance to Phase 3 Trials for Pancreatic Cancer and Melanoma
Clinical Oncologists 40%Biotech Developers 35%Evidence Analysts 25%
2 sources · 69d ago
ExplainerGLP-1 Therapeutics
The Evidence Pack: How Semaglutide Significantly Improves Outcomes in Hard-to-Treat Heart Failure
Clinical Cardiologists 45%Cardiovascular Researchers 35%Health Economists 20%
4 sources · 69d ago
ExplainerDermatology Breakthrough
Phase 3 Trial Shows Sonelokimab Achieves Durable, Near-Complete Clearance in One-Third of Hidradenitis Suppurativa Patients
Dermatologists & Clinicians 40%Patient Advocacy Groups 35%Biotech Analysts 25%
2 sources · 70d ago
Research BriefHepatitis B Cure
The Evidence Pack: How a Novel Antisense Oligonucleotide Achieves a Functional Cure in Chronic Hepatitis B
Clinical Hepatologists 40%Virology & Mechanism Researchers 30%Industry & Public Health Analysts 30%
5 sources · 71d ago
ExplainerGlioblastoma Research
Novel Vitamin B12 Compound Crosses Blood-Brain Barrier to Target Glioblastoma Tumors
Oncology Researchers 47%Clinical Skeptics 35%Patient Advocates 18%
2 sources · 71d ago
Research BriefMetastatic Breast Cancer
FDA Approves Palbociclib to Significantly Extend Progression-Free Survival in HR+/HER2+ Metastatic Breast Cancer
Clinical Oncologists 40%Breast Cancer Researchers 35%Health Economists & Payers 25%
6 sources · 71d ago
ExplainerAutoimmune Breakthrough
The Evidence Pack: How CAR-T Cell Therapy is 'Resetting' the Immune System in Severe Autoimmune Diseases
Clinical Researchers 40%Patient Advocates 30%Biotech Developers 30%
5 sources · 71d ago
Deep DiveGenetic Medicine
The Evidence Pack: How the FDA-Approved Gene Therapy Otarmeni Restores Hearing in Genetic Deafness
Medical Researchers 40%Deaf Culture Advocates 30%Healthcare Payers 30%
4 sources · 71d ago